| Literature DB >> 24915137 |
P Phrakonkham1, J P Brouland2, H El Sheikh Saad3, R Bergès1, C Pimpie3, M Pocard3, M C Canivenc-Lavier1, M Perrot-Applanat4.
Abstract
Endocrine disruptors may play substantial roles in the high incidence of breast cancer. We previously described how early exposure to the mixture of phytoestrogen genistein (G) and the anti-androgen vinclozolin (V) affects peripubertal mammary development. This study evaluates the carcinogenic potential of exposure to V alone or associated with G from conception until weaning in Wistar rats. Dams were exposed to V, G or GV during pregnancy/lactation. At PND50 offspring were treated with DMBA[7,12-dimethylbenz(a)anthracene]. V or GV maternal exposure decreased number of DMBA-induced mammary tumors in the offspring, without significant modifications in tumor incidence, multiplicity and latency. G exposure decreased number of tumors, incidence and multiplicity. Unexpectedly, GV exposure increased tumor volume (p=0.04 vs controls) and epithelial proliferation (p=0.001 vs controls; p=0.005 vs G,V only). All tumors were in situ carcinomas. Concluding, maternal gestation/lactation exposure to a vinclozolin and genistein mixture significantly increases offspring tumor growth without changes in carcinogenesis susceptibility.Entities:
Keywords: Anti-androgen; Endocrine disruption; Gestational and lactational exposure; Mammary gland carcinogenesis; Phytoestrogen
Mesh:
Substances:
Year: 2014 PMID: 24915137 DOI: 10.1016/j.reprotox.2014.05.016
Source DB: PubMed Journal: Reprod Toxicol ISSN: 0890-6238 Impact factor: 3.143